Which are the Parameters to be Controlled in Red Cell Products (Whole Blood, Red Cell Concentrates, Washed Red Cells, Leucocyte Poor Red Cell Concentrates, Frozen Red Cells) in Order that They May be Offered to the Medical Profession as Standardised Products with Specified Properties?
dc.contributor.author | Bayer, William L. | en_US |
dc.contributor.author | Genetet, B. | en_US |
dc.contributor.author | Mannoni, P. | en_US |
dc.contributor.author | Gunson, H. H. | en_US |
dc.contributor.author | Miller, William Y. | en_US |
dc.contributor.author | Myhre, Byron A. | en_US |
dc.contributor.author | Oberman, Harold A. | en_US |
dc.contributor.author | Swisher, Scott N. | en_US |
dc.contributor.author | Zuck, Thomas F. | en_US |
dc.date.accessioned | 2010-06-01T20:08:06Z | |
dc.date.available | 2010-06-01T20:08:06Z | |
dc.date.issued | 1980-10 | en_US |
dc.identifier.citation | Bayer, William L.; Genetet, B.; Mannoni, P.; Gunson, H. H.; Miller, William Y.; Myhre, Byron A.; Oberman, Harold A.; Swisher, Scott N.; Zuck, Thomas F. (1980). "Which are the Parameters to be Controlled in Red Cell Products (Whole Blood, Red Cell Concentrates, Washed Red Cells, Leucocyte Poor Red Cell Concentrates, Frozen Red Cells) in Order that They May be Offered to the Medical Profession as Standardised Products with Specified Properties?." Vox Sanguinis 39(4): 229-240. <http://hdl.handle.net/2027.42/73259> | en_US |
dc.identifier.issn | 0042-9007 | en_US |
dc.identifier.issn | 1423-0410 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/73259 | |
dc.format.extent | 973304 bytes | |
dc.format.extent | 3109 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | 1980 Blackwell Publishing Ltd | en_US |
dc.title | Which are the Parameters to be Controlled in Red Cell Products (Whole Blood, Red Cell Concentrates, Washed Red Cells, Leucocyte Poor Red Cell Concentrates, Frozen Red Cells) in Order that They May be Offered to the Medical Profession as Standardised Products with Specified Properties? | en_US |
dc.type | Article | en_US |
dc.subject.hlbsecondlevel | Oncology and Hematology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | Professor of Pathology Director of Clinical Laboratories and Blood Bank University of Michigan 1335 E. Catherine Street Ann Arbor, MI 48109 (USA) | en_US |
dc.contributor.affiliationum | Professor of Medicine College of Human Medicine Michigan State University East Lansing, Mich. (USA) | en_US |
dc.contributor.affiliationother | Community Blood Center of Greater Kansas City 4040 Main Street Kansas City, MS 64111 (USA) | en_US |
dc.contributor.affiliationother | Centre rÉgional de transfusion sanguine, rue Pierre-Jean-Gineste F-35000 Rennes (France) | en_US |
dc.contributor.affiliationother | Regional Transfusion Centre Roby Street Manchester M1 3BP (England) | en_US |
dc.contributor.affiliationother | American Red Cross Missouri/Illinois Regional Blood Services 4050 Lindell Boulevard St. Louis, MO 63108 (USA) | en_US |
dc.contributor.affiliationother | Professor of Pathology University of California Harbor General Hospital Campus 1000 West Carson Street Torrance, CA 90509 (USA) | en_US |
dc.contributor.affiliationother | Department of Pathology Walter Reed Army Medical Center Washington, DC 20012 (USA) | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/73259/1/j.1423-0410.1980.tb01863.x.pdf | |
dc.identifier.doi | 10.1111/j.1423-0410.1980.tb01863.x | en_US |
dc.identifier.source | Vox Sanguinis | en_US |
dc.identifier.citedreference | 1 Standards for Blood Banks and Transfusion Services; 9th ed. ( AABB, Washington 1978 ). | en_US |
dc.identifier.citedreference | 2 Code of Federal Regulations 21, Food and Drug ( US Government Printing Office, Washington 1978 ). | en_US |
dc.identifier.citedreference | Genetet, B. et Mannoni, P.: La transfusion, pp. 94 – 104 ( Flammarion, Paris 1978 ). | en_US |
dc.identifier.citedreference | Gueguen, M; Genetet, B.; Le Garzic, J. et Marcel, G. A.: FiltrabilitÉ du sang conservÉ. Nouv. Presse mÉd. 7: 2256 – 2257 ( 1978 ). | en_US |
dc.identifier.citedreference | 3 Journ. Off. Rep. fr., 15 mars, p. 2626 ( 1980 ). | en_US |
dc.identifier.citedreference | Risberg, B.: Screen filtration pressure and quantity of micro aggregates: a nonexisting relationship. Transfusion 19: 749 – 753 ( 1979 ). | en_US |
dc.identifier.citedreference | Saint-Blancard, J.; Allary, M.; Bouchet, J. et Fabre, G.: Les nuclÉotides adÉnyliques comme indicateurs de la qualitÉ des sangs ACD et CPD conservÉs. Rev. fr. Transf. XVII: 137 – 145 ( 1974 ). | en_US |
dc.identifier.citedreference | 6 Standards for Blood Banks and Transfusion Services ( AABB, Washington 1978 ). | en_US |
dc.identifier.citedreference | Valeri, C. R.: Viability and function of preserved red cells. New Engl. J. Med. 284: 81 ( 1971 ). | en_US |
dc.identifier.citedreference | Valtis, D. C., and Kennedy, A. C.: Defective gas transport function of stored red blood cells. Lancet i: 119 ( 1954 ). | en_US |
dc.identifier.citedreference | Avoy, D. R., Ellisor, S. S.; Nolan, N. J.; Cox, R. S., Jr.; France, J. A.; Harbury, C. B.; Schrier, S. L., and Pool, J. G.: The effect of delayed refrigeration on red cells, platelet concentrates and cryoprecipitable AHF. Transfusion 18: 160 – 168 ( 1978 ). | en_US |
dc.identifier.citedreference | Dern, R. J.; Gwinn, R. P., and Wiorkowski, J. J.: Studies on the preservation of human blood. Variability in erythrocyte storage characteristics among healthy donors. J. Lab. clin. Med. 67: 955 – 965 ( 1966 ). | en_US |
dc.identifier.citedreference | 3 International Forum: Vox Sang. 34: 111 – 127 ( 1978 ). | en_US |
dc.identifier.citedreference | Zaroulis, C. G.: The importance of red cell 2,3-diphosphoglycerate in transfusion therapy. Haemotherapy in trauma and surgery, pp. 43 – 55 ( AABB, Washington 1979 ). | en_US |
dc.identifier.citedreference | Roberts, S. C.: Cryopreserved red blood cells: a blood component. A seminar on blood components, pp. 37 – 52 ( AABB, Washington 1977 ). | en_US |
dc.identifier.citedreference | Dausset, J.; Fonseca, A. et Brecy, H.: Elimination de certains chocs transfusionnels par l'utilisation de sang appauvri en leukocytes. Vox Sang. 2: 248 – 256 ( 1957 ). | en_US |
dc.identifier.citedreference | Myhre, B. A.: Quality control in blood banking ( Wiley, New York 1974 ). | en_US |
dc.identifier.citedreference | Myhre, B. A.; Nakasako, Y. Y., and Schott, R.: A rapid method for determining the sterility of frozen-reconstituted blood. Transfusion 17: 195 – 202 ( 1975 ). | en_US |
dc.identifier.citedreference | Greenwalt, T. J. and Steane, E. A.: The measurement of glycerol in the presence of citrate. Transfusion 4: 206 – 209 ( 1964 ). | en_US |
dc.identifier.citedreference | Huggins, C. E.: Practical preservation of blood by freezing; in Red cell freezing, a technical workshop, p. 45 ( AABB, Washington 1973 ). | en_US |
dc.identifier.citedreference | Roberts, S. C.: Cryopreserved red blood cells. A blood component; in A seminar on blood components ( AABB, Washington 1977 ). | en_US |
dc.identifier.citedreference | Gibson, J.: Personal communication. M.T. (ASCP). | en_US |
dc.identifier.citedreference | 1 Standards for Blood Banks and Transfusion Services; 9th ed. ( American Association of Blood Banks, Washington 1978 ). | en_US |
dc.identifier.citedreference | Alving, B. M.; Hajuna, Y.; Pisano, B. L.; Mason, B. L.; Buckingham, R. E.; Mozen, M. M., and Finlayson, J. S.: Hypotension associated with prekallikrein activator (Hageman-factor fragments) in plasma protein fraction. New Engl. J. Med. 299: 66 ( 1978 ). | en_US |
dc.identifier.citedreference | Mollison, P. L.: Further observations on the normal survival curve of 51 Cr-labelled red cells. Clin. Sci. 21: 21 ( 1961 ). | en_US |
dc.identifier.citedreference | Beutler, E.: Experimental blood preservatives for liquid storage; in Greenwalt and Jamieson, The human red cell in vitro, p. 189 ( Grune & Stratton, New York 1974 ). | en_US |
dc.identifier.citedreference | Haradin, A. R.; Weed, R. I., and Reed, C. F.: Changes in physical properties of stored erythrocytes. Relationship to survival in vivo.. Transfusion 9: 229 ( 1969 ). | en_US |
dc.identifier.citedreference | 5 Report of Panel 6, Bureau of Biologics, Food and Drug Administration: Safety and Efficacy of Blood and Blood Derivatives ( The Federal Register, in press ). | en_US |
dc.identifier.citedreference | Zuck, T. F.; Bensinger, T. A.; Peck, C. C.; Chillar, R. K.; Beutler, E.; Button, L. N.; McCurdy, P. R.; Josephson, A. M., and Greenwalt, T. J.: The in vivo survival of red blood cells stored in modified CPD with adenine. Report of a multi-institutional cooperative effort. Transfusion 17: 374 – 382 ( 1977 ). | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.